Recently I posted my displeasure at the bleeding disorder community for their unfounded, ridiculous witch-hunt of American Horror Story: Hotel and producer Ryan Murphy’s use of the word hemophilia (hey you all, the show STILL has not premiered).
Why am I writing about it again? Simply put, while everybody, including the National Hemophilia Foundation is whining about something dumb (“It’s not vampires. I prefer the term ‘ancient blood virus.'” and, “It’s really a form of hemophilia in a way. There’s no capes and fangs.”), a REAL atrocity is occurring in not only the bleeding disorder community, but in the world. A travesty we ALL need to be rising up to fight instead of a stupid TV show.
Douchbag of the Decade, Martin Shkreli, recently started his own pharmaceutical company, Turing Pharmaceuticals. What makes this a travesty is Shkreli’s first move after launching his company. He acquired the rights to Daraprim, a drug used to treat life-threatening parasitic infections in people with compromised immune systems, such as AIDS patients and raised the price of the drug from $13.50 to $750 a tablet, a price increase of nearly 5,500 percent!
As a result of the increase, the Infectious Diseases Society of America and the HIV Medicine Association issued a joint letter to Turing calling the drug’s new price “unjustifiable for the medically vulnerable patient population” and “unsustainable for the health care system.”
Shkreli’s response to negative reports? “It really doesn’t make sense to get any criticism for this,” he told the New York Times. “This isn’t the greedy drug company trying to gouge patients. It is us trying to stay in business.” Hate to break the news to you Mr. Shkreli, but in reality, it is you being a douchebag.
Now doesn’t whining about a TV show feel even more silly?